News Related to mNextSpike

Related coverage linked through entity extraction aliases.

Moderna Reports Q4 Revenue Beat Amid Cost Cuts and Regulatory Setback

Feb 17, 2026

Moderna posted Q4 2025 revenue of $678 million, beating analyst estimates despite a 29.8% year-over-year decline. The company reduced operating expenses by 31% while facing FDA refusal to file its flu vaccine application.

Moderna Reports Q4 2025 Results, Cuts Costs 30% Amid FDA Flu Vaccine Setback

Feb 13, 2026

Moderna reported Q4 2025 revenue of $700 million and full-year revenue of $1.9 billion, beating estimates while cutting operating expenses by $2.2 billion. The FDA refused to file the company's seasonal flu vaccine application.